Epstein Secrets

ncisco Chronicle (10/22, Egelko, 2.67M) reports, "A federal appeals court ordered a reduction Thursday in the 15-year, 8-month prison sentence of an Oakland man who talked online of planning to kill thousands of people in the Bay Area, saying the evidence failed to show Amer Alhaggagi was seriously plan

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

es-15668554.php> (10/22, Egelko, 2.67M) reports, "A federal appeals court ordered a reduction Thursday in the 15-year, 8-month prison sentence of an Oakland man who talked online of planning to kill thousands of people in the Bay Area, saying the evidence failed to show Amer Alhaggagi was seriously plann

63> (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health." The drug

ncisco Chronicle (10/22, Egelko, 2.67M) reports, "A federal appeals court ordered a reduction Thursday in the 15-year, 8-month prison sentence of an Oakland man who talked online of planning to kill thousands of people in the Bay Area, saying the evidence failed to show Amer Alhaggagi was seriously plan

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug